ES2040215T3 - Procedimiento para preparar nuevos tiazoles y oxazoles sustituidos. - Google Patents
Procedimiento para preparar nuevos tiazoles y oxazoles sustituidos.Info
- Publication number
- ES2040215T3 ES2040215T3 ES198787102995T ES87102995T ES2040215T3 ES 2040215 T3 ES2040215 T3 ES 2040215T3 ES 198787102995 T ES198787102995 T ES 198787102995T ES 87102995 T ES87102995 T ES 87102995T ES 2040215 T3 ES2040215 T3 ES 2040215T3
- Authority
- ES
- Spain
- Prior art keywords
- group
- substituted
- alkyl
- alkoxy
- carboxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000002916 oxazoles Chemical class 0.000 title abstract 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- 125000003545 alkoxy group Chemical group 0.000 abstract 5
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 4
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 4
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 abstract 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 3
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000004429 atom Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- -1 pyrrolidino, piperidino Chemical group 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 125000002252 acyl group Chemical class 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000002071 phenylalkoxy group Chemical group 0.000 abstract 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 abstract 1
- 150000003557 thiazoles Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Nuevos tiazoles y oxazoles sustituidos de la fórmula general **fórmula** en que A significa un grupo n - alquileno con 2 ó 3 átomos de carbono, eventualmente mono - o di - sustituido con grupos metilo o etilo, X significa un átomo de oxígeno o azufre,R1 significa un átomo de hidrógeno o halógeno, un grupo trifluorometilo, alquilo, fenilo o piperidino o un grupo amino eventualmente sustituido con uno o dos grupos alquilo o un grupo alcanoílo o benzoílo, R2 significa un átomo de hidrógeno o un grupo alquilo, R3 significa un átomo de hidrógeno o un grupo alquilo que puede estar sustituido en las posiciones 2 ó 3 con un grupo hidroxi, ó R3 junto con R4 significan un grupo alcoxicarbonilmetileno o un grupo etileno, pudiendo estar reemplazado el grupo metileno contiguo al átomodeNu Ocon un grupocarbonilo, R4 significa un átomo de hidrógeno, un grupo alquilo eventualmente sustituido con un grupo fenilo, carboxi, alcoxicarbonilo o ciano o sustituido en posiciones 2 ó 3 con un grupo hidroxi, o un grupo alquenilo y R5 significa un grupo hidroxi, alcoxi, carboxi, alcoxicarbonilo, aminocarbonilo, alquilaminocarbonilo o dialquilaminocarbonilo, un grupo alcoxi con 1 a 6 átomos de carbono que está sustituido en posición terminal con un grupo carboxi, alcoxicarbonilo, aminocarbonilo, alquilaminocarbonilo o dialquilaminocarbonilo, un grupo alcoxi con 2 a 7 átomos de carbono que está sustituido en posición terminal con un grupo hidroxi, alcoxi, fenilalcoxi, amino, alquilamino, dialquilamino, pirrolidino, piperidino o hexametilenimino o un grupo etenileno eventualmente sustituido con un grupo alquilo que está sustituido en posición terminal con un grupo carboxi, alcoxicarbonilo, aminocarbonilo, alquilaminocarbonilo o dialquilaminocarbonilo, pudiendo contener todos los grupos alquilo, alcoxi o alcanoílo precedentemente mencionados, en tanto no se indique otra cosa, en cada caso 1 a 3 átomos de carbono y los grupos alquenileno precedentemente mencionados 3 a 5 ástomos de carbono, sus isómeros ópticos y sus diastereoisómeros así comosussales por adicion de ácidos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863608290 DE3608290A1 (de) | 1986-03-13 | 1986-03-13 | Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| DE19863621775 DE3621775A1 (de) | 1986-03-13 | 1986-06-28 | Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2040215T3 true ES2040215T3 (es) | 1993-10-16 |
Family
ID=25841907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES198787102995T Expired - Lifetime ES2040215T3 (es) | 1986-03-13 | 1987-03-03 | Procedimiento para preparar nuevos tiazoles y oxazoles sustituidos. |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US5457205A (es) |
| EP (1) | EP0239815B1 (es) |
| JP (1) | JPH0784446B2 (es) |
| KR (1) | KR870008876A (es) |
| CA (1) | CA1296002C (es) |
| DE (2) | DE3621775A1 (es) |
| DK (1) | DK168991B1 (es) |
| ES (1) | ES2040215T3 (es) |
| FI (1) | FI87777C (es) |
| GR (1) | GR3002839T3 (es) |
| HK (1) | HK106494A (es) |
| HU (1) | HU196974B (es) |
| IE (1) | IE59800B1 (es) |
| IL (1) | IL81874A (es) |
| MX (1) | MX9202818A (es) |
| NO (1) | NO172849C (es) |
| PH (1) | PH23996A (es) |
| PL (1) | PL154772B1 (es) |
| PT (1) | PT84462B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3805382A1 (de) * | 1988-02-20 | 1989-08-31 | Boehringer Ingelheim Vetmed | Verwendung von thiazolen zur leistungssteigerung bei tieren |
| JP3003148B2 (ja) * | 1989-01-05 | 2000-01-24 | 藤沢薬品工業株式会社 | チアゾール化合物、その製造法およびそれを含有する医薬組成物 |
| AU660187B2 (en) * | 1991-07-22 | 1995-06-15 | Pfizer Inc. | Chiral intermediates for the preparation of antidiabetics thiazoles |
| WO1995002586A1 (en) * | 1993-07-14 | 1995-01-26 | Taisho Pharmaceutical Co., Ltd. | 5-acetylthiazoline oxime derivative |
| US6472387B1 (en) | 1996-10-07 | 2002-10-29 | Eli Lilly And Company | Methods of using compounds as neuro-protective agents |
| CA2270661A1 (en) * | 1996-10-07 | 1998-04-16 | Lawrence Joseph Heinz | Novel compounds useful as neuro-protective agents |
| US6121288A (en) * | 1996-11-08 | 2000-09-19 | Nippon Chemiphar Co., Ltd. | Visceral fat lowering agent |
| AU9575698A (en) | 1997-10-06 | 1999-04-27 | Eli Lilly And Company | Novel compounds useful as neuro-protective agents |
| US5972099A (en) * | 1997-12-17 | 1999-10-26 | Bayer Corporation | Process for preparing organic pigment compositions |
| US6121300A (en) * | 1998-11-10 | 2000-09-19 | Wagle; Dilip R. | Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts |
| EP1353918B1 (en) * | 2000-11-28 | 2005-01-12 | Smithkline Beecham Plc | Morpholine derivatives as antagonists of orexin receptors |
| ES2353601T3 (es) * | 2003-04-15 | 2011-03-03 | Wellstat Therapeutics Corporation | Compuestos para el tratamiento de trastornos metabólicos. |
| CN1777576A (zh) | 2003-04-22 | 2006-05-24 | 维尔斯达医疗公司 | 用于治疗代谢紊乱的化合物 |
| GB0324654D0 (en) * | 2003-10-22 | 2003-11-26 | Glaxo Group Ltd | Medicinal compounds |
| TW200526588A (en) * | 2003-11-17 | 2005-08-16 | Smithkline Beecham Corp | Chemical compounds |
| WO2013062881A1 (en) * | 2011-10-27 | 2013-05-02 | Merck Sharp & Dohme Corp. | Process for making beta 3 agonists and intermediates |
| US10791890B2 (en) | 2018-03-27 | 2020-10-06 | Omachron Intellectual Property Inc. | Surface cleaning apparatus |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3225042A (en) * | 1962-07-31 | 1965-12-21 | Lilly Co Eli | Hydroxymorpholines |
| US3514465A (en) * | 1966-12-30 | 1970-05-26 | Degussa | Certain thiazolyl- and pyridinylaminoketones |
| LU69079A1 (es) * | 1973-12-27 | 1975-08-20 | ||
| DD144050A5 (de) * | 1978-06-05 | 1980-09-24 | Ciba Geigy Ag | Verfahren zur herstellung von n-alkylierten aminoalkoholen |
| IE50355B1 (en) * | 1979-10-20 | 1986-04-02 | Wyeth John & Brother Ltd | Morpholine derivatives |
| GB8418657D0 (en) * | 1984-07-21 | 1984-08-22 | Beecham Group Plc | Compounds |
| US4826990A (en) * | 1987-09-30 | 1989-05-02 | American Home Products Corporation | 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents |
-
1986
- 1986-06-28 DE DE19863621775 patent/DE3621775A1/de not_active Ceased
-
1987
- 1987-03-03 DE DE8787102995T patent/DE3771541D1/de not_active Expired - Lifetime
- 1987-03-03 ES ES198787102995T patent/ES2040215T3/es not_active Expired - Lifetime
- 1987-03-03 EP EP87102995A patent/EP0239815B1/de not_active Expired - Lifetime
- 1987-03-10 PL PL1987264545A patent/PL154772B1/pl unknown
- 1987-03-11 CA CA000531681A patent/CA1296002C/en not_active Expired - Lifetime
- 1987-03-11 FI FI871052A patent/FI87777C/fi not_active IP Right Cessation
- 1987-03-12 PT PT84462A patent/PT84462B/pt not_active IP Right Cessation
- 1987-03-12 DK DK127487A patent/DK168991B1/da active
- 1987-03-12 JP JP62055477A patent/JPH0784446B2/ja not_active Expired - Lifetime
- 1987-03-12 IL IL81874A patent/IL81874A/xx not_active IP Right Cessation
- 1987-03-12 NO NO871028A patent/NO172849C/no unknown
- 1987-03-12 IE IE64487A patent/IE59800B1/en not_active IP Right Cessation
- 1987-03-12 HU HU871084A patent/HU196974B/hu not_active IP Right Cessation
- 1987-03-13 PH PH35027A patent/PH23996A/en unknown
- 1987-03-13 KR KR870002258A patent/KR870008876A/ko not_active Ceased
-
1991
- 1991-10-03 GR GR91401473T patent/GR3002839T3/el unknown
-
1992
- 1992-06-12 MX MX9202818A patent/MX9202818A/es unknown
-
1993
- 1993-03-12 US US08/030,744 patent/US5457205A/en not_active Expired - Fee Related
-
1994
- 1994-10-06 HK HK106494A patent/HK106494A/xx not_active IP Right Cessation
-
1995
- 1995-05-24 US US08/449,174 patent/US5604225A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PT84462A (de) | 1987-04-01 |
| KR870008876A (ko) | 1987-10-21 |
| MX9202818A (es) | 1992-06-30 |
| HUT44246A (en) | 1988-02-29 |
| DK127487A (da) | 1987-09-14 |
| FI871052A0 (fi) | 1987-03-11 |
| PL264545A1 (en) | 1988-07-21 |
| JPS62226971A (ja) | 1987-10-05 |
| PH23996A (en) | 1990-02-09 |
| US5457205A (en) | 1995-10-10 |
| FI871052A7 (fi) | 1987-09-14 |
| US5604225A (en) | 1997-02-18 |
| NO871028D0 (no) | 1987-03-12 |
| DE3771541D1 (de) | 1991-08-29 |
| DE3621775A1 (de) | 1988-01-07 |
| HK106494A (en) | 1994-10-14 |
| IL81874A0 (en) | 1987-10-20 |
| JPH0784446B2 (ja) | 1995-09-13 |
| EP0239815B1 (de) | 1991-07-24 |
| NO172849C (no) | 1993-09-15 |
| CA1296002C (en) | 1992-02-18 |
| IE870644L (en) | 1987-09-13 |
| DK127487D0 (da) | 1987-03-12 |
| NO172849B (no) | 1993-06-07 |
| PT84462B (pt) | 1989-10-04 |
| IE59800B1 (en) | 1994-04-06 |
| DK168991B1 (da) | 1994-07-25 |
| EP0239815A1 (de) | 1987-10-07 |
| GR3002839T3 (en) | 1993-01-25 |
| NO871028L (no) | 1987-09-14 |
| FI87777C (fi) | 1993-02-25 |
| IL81874A (en) | 1991-01-31 |
| HU196974B (en) | 1989-02-28 |
| PL154772B1 (en) | 1991-09-30 |
| FI87777B (fi) | 1992-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT95870A (pt) | Metodo para a preparacao de taxol que utiliza uma oxazinona | |
| ES473074A1 (es) | Un procedimiento para la preparacion de derivados de tieno- tiacina | |
| DK114783A (da) | Hidtil ukendte forbindelser, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler | |
| PT90623A (pt) | Processo para a preparacao de n-heterociclil-4-guanilalquil-benzamidas uteis como inibidores de protease | |
| FR2398718A1 (fr) | Nouvelles amines primaires utiles a la preparation de derives d'aminoalkyl benzenes | |
| ES2055368T3 (es) | Procedimiento para la preparacion enantioselectiva de derivados de la fenilisoserina. | |
| SE8104783L (sv) | Heterocykliska foreningar | |
| ATE66240T1 (de) | Phenolische korrosionsinhibitoren fuer anstrichstoffe. | |
| ES481917A1 (es) | Procedimiento para la preparacion de nuevos acidos tiazol-2-oxamicos sustituidos en posicion 4. | |
| ES2000312A6 (es) | Un procedimiento para preparar derivados de dihidroperidaazinona | |
| ES485096A1 (es) | Un procedimiento para preparar aminoglicosidos | |
| ES474600A1 (es) | Procedimiento para la preparacion de isotiazol-3(2h)-on-1,1-dioxidos condensados | |
| MX12708A (es) | Derivados de oxima de 1,2,5,6-tetrahidropiridina yprocedimiento para su preparacion | |
| SE7704616L (sv) | Sett att framstella nya 11-desoxi-prostaglandin-fÿ2-derivat | |
| ES473464A1 (es) | Procedimiento para la preparacion de nuevos derivados de 5,-11-dihidro-6h-pirido (2,3-b)(1,4)benzodiazepin-6-ona. | |
| ES461796A1 (es) | Un procedimiento para la preparacion de nuevos derivados de tiofeno. | |
| ES471239A1 (es) | Un metodo para la produccion de compuestos de tiazolidina | |
| ES476408A1 (es) | Un procedimiento de preparacion de derivados de 2,4-tiazoli-dindiona. | |
| DK0412907T3 (da) | Estere af organiske syrer med alkoholer afledt af 19-norsteroider og deres salte, en fremgangsmåde til deres fremstilling, mellemprodukter ved denne fremgangsmåde, deres anvendelse som lægemidler samt præparater med indhold deraf | |
| ES481119A1 (es) | Procedimiento para preparar compuestos nitro. | |
| ES470784A1 (es) | Procedimiento para la preparacion de aminoalcoxibenzofuranos | |
| ES453121A1 (es) | Un metodo de preparacion de nuevos derivados de piridil u- reas. | |
| ES462746A1 (es) | Procedimiento para la preparacion de nuevas piridobenzodia- zepinas. | |
| ES477076A1 (es) | Un procedimiento de preparacion de derivados de acido 1-naf-til-acetico. | |
| DE69023408D1 (de) | Glykosidasehemmende Piperidinverbindungen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 239815 Country of ref document: ES |